Damora Therapeutics (DMRA) Treasury Shares (2019 - 2026)
Damora Therapeutics (DMRA) posted Treasury Shares of $957513.0 for Q1 2026, up 12175.81% on a QoQ basis from $7800.0 in Q4 2025, and up 9061.05% year-over-year from $10452.0 in Q1 2025.
Damora Therapeutics (DMRA) Treasury Shares (2019 - 2026) Analysis & Trends
Damora Therapeutics' Treasury Shares history runs 5 years deep, the most recent figure standing at $957513.0 for Q1 2026.
- Quarterly Treasury Shares rose 9061.05% year-over-year to $957513.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $957513.0 (up 9061.05% YoY) and the FY2025 annual result came in at $7800.0, down 50.0% from the prior year.
- Treasury Shares was $957513.0 for Q1 2026 at Damora Therapeutics, up from $7800.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $957513.0 in Q1 2026 and bottomed at $161.0 in Q4 2024.
- A 3-year average of $281753.1 and a median of $10452.0 in 2025 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2025 — Treasury Shares plunged 98.73% — and 2026, when it jumped 9061.05%.
- Damora Therapeutics' Treasury Shares stood at $161.0 in 2024, then jumped by 4744.72% to $7800.0 in 2025, then surged by 12175.81% to $957513.0 in 2026.
- Business Quant data shows DMRA's Treasury Shares at $957513.0 in Q1 2026, $7800.0 in Q4 2025, and $7800.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - | 957,513.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 957,513.00 |
| Mar 31, 2026 | 957,513.00 |
| Dec 31, 2025 | 7,800.00 |
| Dec 31, 2025 | 7,800.00 |
| Sep 30, 2025 | 7,800.00 |
| Sep 30, 2025 | 7,800.00 |
| Jun 30, 2025 | 10,452.00 |
| Jun 30, 2025 | 10,452.00 |
| Mar 31, 2025 | 10,452.00 |
| Mar 31, 2025 | 10,452.00 |
| Dec 31, 2024 | 161.00 |
| Dec 31, 2024 | 161.00 |
| Sep 30, 2024 | 16,600.00 |
| Sep 30, 2024 | 16,600.00 |
| Jun 30, 2024 | 705,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Mar 31, 2024 | 820,000.00 |
| Mar 31, 2024 | 820,000.00 |
| Sep 30, 2020 | 4.13 Mn |
| Sep 30, 2020 | 4.13 Mn |